Subsequent mammography reduces recall and increases breast cancer detection: an audit of a screening program.

IF 1.4
Erika Marina Solla Negrao, Mariana Alves Almeida, Emanuele Françoso Cardoso, Alvaro Silva Almeida, Samanta Santos Sousa, Cassio Cardoso-Filho, Rodrigo Menezes Jales, Diama Bhadra Vale
{"title":"Subsequent mammography reduces recall and increases breast cancer detection: an audit of a screening program.","authors":"Erika Marina Solla Negrao, Mariana Alves Almeida, Emanuele Françoso Cardoso, Alvaro Silva Almeida, Samanta Santos Sousa, Cassio Cardoso-Filho, Rodrigo Menezes Jales, Diama Bhadra Vale","doi":"10.61622/rbgo/2025rbgo89","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze recall rates in a public breast cancer screening facility in Campinas, Brazil.</p><p><strong>Methods: </strong>A prospective assessment of outcomes on screening mammographies (MMG) between July 2023 and August 2024. BI-RADS® 0,4/5 indicated positive results, and women recalled. The variables were age, whether first or subsequent MMG, and biopsy (cancer positive or negative). The outcomes were recall rate and cancer detection rate on the recall (CDR). Prevalence ratio with 95% confidence interval (PR) estimated the risk.</p><p><strong>Results: </strong>There were included 19,377 MMG on women over 40: 15,983 subsequent MMG (82.5%), and 1,646 women recalled (BR 0,4/5). Adherence to recall was over 99%. The recall rates were 12.4% at first and 7.7% at subsequent MMG. Recall rate was 1.6 times higher at first than at subsequent MMG (PR 1.61;1.45-1.79). CDR was higher at subsequent MMG. A first MMG reduced the risk of cancer detection by 71% (PR 0.29-0.15;0.58). Compared to women 50-69, there were no differences in the risks of recall and cancer detection at first MMG. At subsequent MMG the recall risk was higher in women 40-49 (PR 1.16;1.03-1.30), and over 69 (PR 1.47;1.03-2.12). The risk of cancer detection was 60% lower in women 40-49 (PR 0.60;0.36-0.99), and 2.7 times higher in women over 69 (PR 2.78;1.32-5.84).</p><p><strong>Conclusion: </strong>The recall rates were 12.4% at first and 7.7% at subsequent MMG. Adherence was high. Screening efficiency was higher in women 50-69. At subsequent screenings women 40-49 showed a higher recall rate and a lower CDR when compared to women 50-69.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671671/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.61622/rbgo/2025rbgo89","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To analyze recall rates in a public breast cancer screening facility in Campinas, Brazil.

Methods: A prospective assessment of outcomes on screening mammographies (MMG) between July 2023 and August 2024. BI-RADS® 0,4/5 indicated positive results, and women recalled. The variables were age, whether first or subsequent MMG, and biopsy (cancer positive or negative). The outcomes were recall rate and cancer detection rate on the recall (CDR). Prevalence ratio with 95% confidence interval (PR) estimated the risk.

Results: There were included 19,377 MMG on women over 40: 15,983 subsequent MMG (82.5%), and 1,646 women recalled (BR 0,4/5). Adherence to recall was over 99%. The recall rates were 12.4% at first and 7.7% at subsequent MMG. Recall rate was 1.6 times higher at first than at subsequent MMG (PR 1.61;1.45-1.79). CDR was higher at subsequent MMG. A first MMG reduced the risk of cancer detection by 71% (PR 0.29-0.15;0.58). Compared to women 50-69, there were no differences in the risks of recall and cancer detection at first MMG. At subsequent MMG the recall risk was higher in women 40-49 (PR 1.16;1.03-1.30), and over 69 (PR 1.47;1.03-2.12). The risk of cancer detection was 60% lower in women 40-49 (PR 0.60;0.36-0.99), and 2.7 times higher in women over 69 (PR 2.78;1.32-5.84).

Conclusion: The recall rates were 12.4% at first and 7.7% at subsequent MMG. Adherence was high. Screening efficiency was higher in women 50-69. At subsequent screenings women 40-49 showed a higher recall rate and a lower CDR when compared to women 50-69.

Abstract Image

随后的乳房x光检查减少了回忆,增加了乳腺癌的检测:对筛查项目的审计。
目的:分析巴西坎皮纳斯市一家公共乳腺癌筛查机构的召回率。方法:对2023年7月至2024年8月期间筛查性乳房x线检查(MMG)的结果进行前瞻性评估。BI-RADS®0,4/5显示阳性结果,女性被召回。变量包括年龄、首次或后续MMG、活检(癌症阳性或阴性)。结果为召回率和肿瘤检出率(CDR)。患病率以95%置信区间(PR)估计风险。结果:40岁以上女性纳入了19377例MMG, 15983例(82.5%),1646例女性被召回(BR 0,4/5)。召回的依从性超过99%。第一次召回率为12.4%,随后的召回率为7.7%。召回率比随后的MMG高1.6倍(PR为1.61;1.45-1.79)。CDR在随后的MMG中更高。第一次MMG降低了71%的癌症检测风险(PR 0.29-0.15;0.58)。与50-69岁的女性相比,第一次MMG时的回忆和癌症检测风险没有差异。在随后的MMG中,40-49岁女性的召回风险更高(PR为1.16;1.03-1.30),69岁以上女性的召回风险更高(PR为1.47;1.03-2.12)。40-49岁的女性患癌风险低60% (PR为0.60;0.36-0.99),69岁以上的女性患癌风险高2.7倍(PR为2.78;1.32-5.84)。结论:首次用药召回率为12.4%,后续用药召回率为7.7%。依从性很高。50-69岁女性的筛查效率更高。在随后的筛查中,与50-69岁的女性相比,40-49岁的女性表现出更高的回忆率和更低的CDR。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书